Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dr Ashkan and Dr Liau are the most humble of ROCK STARS that neuroscience has to offer. I strive as a health care professional to achieve their level of care and expertise!
As a CVS retail pharmacist, I can assure you that we receive items stored at -50 fFahrenheit relatively often. I don’t see us on a retail level ever giving a DCVax injection however. Maybe arranged thru CVS Specialty and delivered to an oncologist’s office, but probably not thru retail.
Dr Murthy??
The answer is contained within the question. “Self” identifies “self” in normal tissue. You essentially can not sensitize your own dendritic cells to attack other normal cells and tissue in your own body. Dendritic cells are designed to recognize and properly detect and respond to non self which displays non-self antigens.
I got it in one- THANKS ALOT FLIPPER (seriously please don’t do that again)
And then I woke up! Lol
As much as I am a proponent of NWBO and the value of their services, I agree. We can’t keep setting ourselves up for a fall.
Not that I think that the 3 million has to do with any BP but- if you’ve ever watched the show “Shark Tank”- sometimes the money invested by the “shark” is less beneficial to the entrepreneur than the influence gained by the shark?
This post should be stickied. It has successfully embraced my sentiments regarding the lawsuit and our potential as a group of ordinarily supportive shareholders to inadvertently destroy the very positive story we have with DCVax. Thank you Biosectinvestor.
Thanks for sending the article as feedback. I hadn’t had the opportunity to do that yet!
https://www.medscape.org/viewarticle/988563
The above link to continuing education sponsored by Novacure lacked any mention of the only GBM TRIAL to show statistically significant results in 20 years…Hmmm
Do we have to wait for MAA approval before we find out how nice NICE is with reimbursement?
I can’t believe we are taking a fantastic victory and throwing shade on it just because of when an announcement was made.
There was no “botched timing”. As much as respect your opinions on this board, I don’t agree with your comment. As an average shareholder, I feel I was more than adequately informed
Either way, NW has no control over the releases of the MHRA. The fact remains that it was great news that they PRed in an appropriate amount of time.
My understanding from previous posts on this board is that most MIA announcements occur between 3-5pm est. Even if it had occurred between 3 and 4 pm during market hours, would it have really been possible to get a PR out before the 4 pm closing and would that have satisfied people more than what was done?
If they waited till morning, they would have had many upset that they didn’t PR it last night. The MHRA are the ones that essentially PR’d it yesterday afternoon, kudos to NWBO for doing what they said they would do and sending out a PR right after it happened. It seems like they can’t win regardless?
Well, I did it. After years of my policy of no buying no selling, I scrapped together enough funds to buy some more. A drop in the bucket compared to some, but well worth it!
And by October 2020…
Glad to see you’re back. Hope you had a nice time off.
You said,
Bottom line, valid time lines bring big investors. There is no absolute timeline yet.
Another reason I have always preached patience when waiting for the prize that I’ve had my eyes on for the last five years! The time lines will materialize when Ms Powers has more control over them.
I would like to believe it is not ‘baked in’ either. The only way the stock will behave in a consistent upside fashion would be for there to be more PRs shortly following the MIA acceptance. As much as I dislike the short narrative, we will spike (probably within 10cents) at MIA acceptance and then quickly fall again to the 60s until more good news. Good, awesome, news is coming- more patience is required for the future when multiple RAs are involved and processes must be validated. I have faith in our future and believe we will get to the goal of being able to provide DCVAX to the masses.
Results were definitely FDA approvable. Everyone is probably just upset because no buy out was announced. Give it time, it’ll bounce back.
I concur with Margin Buu. Your reposting of the Tweets is most appreciated. I look forward every morning to seeing your posts!
Very good line of thinking, Smokey!
Yes, true that! Just really would miss the great due diligence (medical related) that I glean from it’s posters. I’m just sayin that the more we dwell on a lawsuit that probably won’t show any results within the next 3 years- the more people lose sight of the true value of what we have and have to gain within the next few months.
I’m reaching a point of exhaustion as people continue to post (positive and negative) about NWBOs lawsuit endeavors. This is a biotech stock. Let’s continue to support the medical related catalysts that will surely occur before anything major happens on the legal fronts. We have a winner here - even without a lawsuit!
One would argue that, as a long holder of company stock, you are already a stakeholder in it’s outcome…
Okay, even if we were to believe the news was bad (which 70 coauthors and all longs here would dispute), it is not the normal selling of an equity because of news that our lawsuit is about. NWBO is claiming that the MM s are/were spoofing our stock on pivotal days and therefore giving the false impression of a company that is struggling with a presentation of bad news when it is widely held that the news is indeed good!
I’m sorry if this was asked before but do you believe the conference today at RI was what LP was alluding to at the ASM?
Or maybe JJ spent enough time with other members of the board to realize they have his best interest as a shareholder at heart?
Keeping in mind Ex’s response as well, it just wouldn’t seem to be a leap to expect them to submit to MHRA and FDA in a short time span. Here’s to hoping!
Thank you for your reply ex. With the company using both facilities to manufacture DCAX (Advent and CRL) and with their plans to have them overlap each other to create redundancy, I can imagine that both facilities would be scrutinized by each RA involved. Overall though, the general submission to each agency should be similar save plans to procure and deliver DCVAX by the contract manufacturers.
One would wonder- maybe someone more familiar with the process could answer- are there significant differences between the submission to the FDA vs MHRA? I mean, the trial data doesn’t change. Make two copies and send to both? Or else count on Orbis participation?
Nicely said. I agree with your timeline.
I keep thinking of the 60 minutes story many years ago when they showcased TTF fields as a way to inhibit cancer growth. If only 60 minutes could do a story on our science. As an aside, they could even go into the information we know about the forces other companies use (both financial and scientific) to make sure we don’t succeed…
While I’ll admit there ARE pumpers on this board, your list of pumpers IMO isn’t accurate. Many defend against FUD without pumping. Agreed, however on those that said ‘big things are happening’ without citing evidence!
I would much prefer that they spend their time focused on gaining approvals. I don’t think that they should dedicate even one more minute defending their science (they hired a law firm to handle the financial misdeeds). The JAMA paper speaks for itself and most people understand and can easily see the conflicts of interest of those presenting an opposite view.
There was ABSOLUTELY nothing wrong with the ASM. Linda set out to describe to anyone listening the forces that are present- whether working for or against the company. Management shares the same passion that us shareholders have for bringing DCVAX to market. Like every other company, no matter how badly everyone would like to see approvals go quicker, there is no substitute for following the rules and procedures and doing it right. Linda was candid in her opinions and my take was that she was quite positive in our prospects in getting DCVAX to market.